BioNTech SE (BNTX) Change in Accured Expenses (2018 - 2021)
BioNTech SE's Change in Accured Expenses history spans 4 years, with the latest figure at $844365.3 for Q1 2021.
- On a quarterly basis, Change in Accured Expenses rose 91.22% to $844365.3 in Q1 2021 year-over-year; TTM through Mar 2021 was -$1.6 million, a N/A change, with the full-year FY2020 number at $2388.2, up 25.66% from a year prior.
- Change in Accured Expenses hit $844365.3 in Q1 2021 for BioNTech SE, up from $441575.6 in the prior quarter.
- Over the last five years, Change in Accured Expenses for BNTX hit a ceiling of $844365.3 in Q1 2021 and a floor of -$1.5 million in Q4 2018.
- Historically, Change in Accured Expenses has averaged -$402109.9 across 4 years, with a median of -$488330.4 in 2020.
- Biggest five-year swings in Change in Accured Expenses: rose 3.92% in 2019 and later surged 91.22% in 2021.
- Tracing BNTX's Change in Accured Expenses over 4 years: stood at -$1.5 million in 2018, then increased by 3.92% to -$1.4 million in 2019, then soared by 131.14% to $441575.6 in 2020, then surged by 91.22% to $844365.3 in 2021.
- Business Quant data shows Change in Accured Expenses for BNTX at $844365.3 in Q1 2021, $441575.6 in Q1 2020, and -$1.4 million in Q4 2019.